LISA GUSTAS: Open Payments
NPI 1306921051 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $44 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $148 |
| Regeneron Healthcare Solutions, Inc. | 3 | $86 |
| Ipsen Biopharmaceuticals, Inc | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| GENZYME CORPORATION | 1 | $33 |
| Mirum Pharmaceuticals, Inc. | 1 | $21 |
| QOL Medical, LLC | 1 | $21 |
Products named: TREMFYA, DUPIXENT, Bylvay, EOHILIA, Livmarli, Sucraid.
Industry payments across CO — which companies pay providers there.
